Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bryan Williams

Showing results (271-280 of 417) with videos related to

Pageof 42
Sort By:
European Heart Journal|July 27, 2022
Hypertension in children and adolescentsGiovanni de Simone, Costantino Mancusi, Henner Hanssen, et al.
Hypertension (Dallas, Tex. : 1979)|March 4, 2026
Interplay of Age and Sex With Clinic and Ambulatory Blood Pressure and MortalityMichael Böhm, Alejandro de la Sierra, Igor Schwantke, et al.
Neuropharmacology|June 8, 2011
Transient receptor potential vanilloid 1 agonists modulate hippocampal CA1 LTP via the GABAergic systemDouglas Bennion, Tyron Jensen, Curtis Walther, et al.
The Lancet. Diabetes & Endocrinology|April 16, 2018
Endocrine and haemodynamic changes in resistant hypertension, and blood pressure responses to spironolactone or amiloride: the PATHWAY-2 mechanisms substudiesBryan Williams, Thomas M MacDonald, Steve V Morant, et al.
BMJ Open|February 17, 2021
Prospective meta-analysis protocol on randomised trials of renin-angiotensin system inhibitors in patients with COVID-19: an initiative of the International Society of HypertensionSonali Rukshana Gnanenthiran, Claudio Borghi, Dylan Burger, et al.
Lancet (London, England)|May 15, 2020
Estimating excess 1-year mortality associated with the COVID-19 pandemic according to underlying conditions and age: a population-based cohort studyAmitava Banerjee, Laura Pasea, Steve Harris, et al.
European Heart Journal|March 29, 2019
Cardiovascular outcomes and achieved blood pressure in patients with and without diabetes at high cardiovascular riskMichael Böhm, Helmut Schumacher, Koon K Teo, et al.
Journal of the American Heart Association|November 20, 2017
Combination Therapy Is Superior to Sequential Monotherapy for the Initial Treatment of Hypertension: A Double-Blind Randomized Controlled TrialThomas M MacDonald, Bryan Williams, David J Webb, et al.
European Journal of Preventive Cardiology|July 18, 2025
Long-term outcomes following radiofrequency renal denervation: meta-analysis of 18 reportsFelix Mahfoud, David E Kandzari, Markus P Schlaich, et al.
European Heart Journal|January 18, 2018
Clinical recommendations for high altitude exposure of individuals with pre-existing cardiovascular conditions: A joint statement by the European Society of Cardiology, the Council on Hypertension of the European Society of Cardiology, the European Society of Hypertension, the International Society of Mountain Medicine, the Italian Society of Hypertension and the Italian Society of Mountain MedicineGianfranco Parati, Piergiuseppe Agostoni, Buddha Basnyat, et al.
Pageof 42

Showing results (271-280 of 417) with videos related to

Sort By:
Pageof 42
European Heart Journal|July 27, 2022
Hypertension in children and adolescentsGiovanni de Simone, Costantino Mancusi, Henner Hanssen, et al.
Hypertension (Dallas, Tex. : 1979)|March 4, 2026
Interplay of Age and Sex With Clinic and Ambulatory Blood Pressure and MortalityMichael Böhm, Alejandro de la Sierra, Igor Schwantke, et al.
Neuropharmacology|June 8, 2011
Transient receptor potential vanilloid 1 agonists modulate hippocampal CA1 LTP via the GABAergic systemDouglas Bennion, Tyron Jensen, Curtis Walther, et al.
The Lancet. Diabetes & Endocrinology|April 16, 2018
Endocrine and haemodynamic changes in resistant hypertension, and blood pressure responses to spironolactone or amiloride: the PATHWAY-2 mechanisms substudiesBryan Williams, Thomas M MacDonald, Steve V Morant, et al.
BMJ Open|February 17, 2021
Prospective meta-analysis protocol on randomised trials of renin-angiotensin system inhibitors in patients with COVID-19: an initiative of the International Society of HypertensionSonali Rukshana Gnanenthiran, Claudio Borghi, Dylan Burger, et al.
Lancet (London, England)|May 15, 2020
Estimating excess 1-year mortality associated with the COVID-19 pandemic according to underlying conditions and age: a population-based cohort studyAmitava Banerjee, Laura Pasea, Steve Harris, et al.
European Heart Journal|March 29, 2019
Cardiovascular outcomes and achieved blood pressure in patients with and without diabetes at high cardiovascular riskMichael Böhm, Helmut Schumacher, Koon K Teo, et al.
Journal of the American Heart Association|November 20, 2017
Combination Therapy Is Superior to Sequential Monotherapy for the Initial Treatment of Hypertension: A Double-Blind Randomized Controlled TrialThomas M MacDonald, Bryan Williams, David J Webb, et al.
European Journal of Preventive Cardiology|July 18, 2025
Long-term outcomes following radiofrequency renal denervation: meta-analysis of 18 reportsFelix Mahfoud, David E Kandzari, Markus P Schlaich, et al.
European Heart Journal|January 18, 2018
Clinical recommendations for high altitude exposure of individuals with pre-existing cardiovascular conditions: A joint statement by the European Society of Cardiology, the Council on Hypertension of the European Society of Cardiology, the European Society of Hypertension, the International Society of Mountain Medicine, the Italian Society of Hypertension and the Italian Society of Mountain MedicineGianfranco Parati, Piergiuseppe Agostoni, Buddha Basnyat, et al.
Pageof 42